HLA-DRA1*0101 & HLA-DRB1*1101 & CLIP (PVSKMRMATPLLMQA)

HLA-DRA1*0101 & HLA-DRB1*1101 & CLIP (PVSKMRMATPLLMQA) 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • Human (1)

  • 태그

    His Tag & Avi Tag (1)

  • 마커

    Biotin-labeled (1)

제품 번호발현 시스템제품 설명단백질 구조순도특성
HLP-H82Ed
Human
HEK293
Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01&CLIP (PVSKMRMATPLLMQA) Complex Protein (Monomer)
총 수량1
  • 1

HLA-DRA1*0101 & HLA-DRB1*1101 & CLIP (PVSKMRMATPLLMQA)분자 배경

HLA-DR is a isotype of MHC Class II responsible for presenting foreign antigens to the immune system's helper T-cells. The CLIP peptide, derived from the invariant chain, occupies the peptide-binding groove of the newly synthesized HLA-DR molecule to prevent it from loading irrelevant peptides inside the cell.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
NapabucasinDP1; DP2A; BB-608; GB-201; BBI-608; BBI-608-DP1; BBI-608-DP2A; Z1HHM49K7O (UNII code)Phase 3 Clinical1globe Biomedical Co Ltd, Pharmaceutics International Inc, Boston Biomedical IncHematologic Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Neoplasms; Glioblastoma; Mesothelioma; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms
상세
Nanocurcumin (Tehran University of Medical Sciences)Phase 2 ClinicalTehran University Of Medical SciencesNeoplasms; Periapical Diseases
상세
OPB-111077OPB-111077Phase 2 ClinicalOtsuka Pharmaceutical Co LtdLymphoma, B-Cell; Solid tumours; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Leukemia, Myeloid, Acute; Carcinoma, Hepatocellular
상세
DanvatirsenAZD-9150; STAT-3Rx; ISIS-345794; ISIS-481464; ISIS-STAT3Rx; IONIS-STAT3Rx; ISIS-STAT3-2.5Rx; IONIS-STAT3-2.5RxPhase 2 ClinicalIonis Pharmaceuticals IncOvarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Mismatch Repair Deficient Cancer; Lymphoma, Large B-Cell, Diffuse; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Ascites; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms
상세
HL-237HL-237Phase 2 ClinicalHanlim Pharmaceutical Co LtdArthritis, Rheumatoid
상세
M-1001M-1001; MEDICA-M1001Phase 2 ClinicalSyndromexDyslipidemias
상세
NT-219NT-219; NT219Phase 2 ClinicalTyrNovo LtdSolid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Neoplasm Metastasis
상세
Dimethylaminomicheliolide FumarateACT-001Phase 2 ClinicalTianjin Accendatech Technology Co LtdGlioblastoma; Small Cell Lung Carcinoma; Ganglioglioma; Central Nervous System Neoplasms; Optic Neuritis; Neuromyelitis Optica; Breast Neoplasms; Glioma; Brain metastases; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma
상세
C-188-9C188-9; C-188-9; TTI-101Phase 2 ClinicalBaylor College Of MedicineLiver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Neoplasms; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
상세
WP-1066WP-1066Phase 2 ClinicalThe University Of Texas MD Anderson Cancer CenterMedulloblastoma; Glioblastoma; Neoplasms; Brain Neoplasms; Brain metastases; Glioma; Melanoma
상세
YY-201YY-201; YY201Phase 1 ClinicalShanghai Yuyao Biotechnology Co LtdHematologic Neoplasms; Solid tumours; Prostatic Hyperplasia
상세
GLG-302GLG-302; GLG-805; S31-201; NSC-74859Phase 1 ClinicalH Lee Moffitt Cancer Center & Research InstituteBreast Neoplasms
상세
MOL-4239MOL-4239; WP-1220Phase 1 ClinicalThe University Of Texas MD Anderson Cancer CenterPsoriasis; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides
상세
Amcasertib/NapabucasinPhase 1 ClinicalBoston Biomedical IncNeoplasms
상세
ST-2286ST-2286; JW2286; JW-2286Phase 1 ClinicalC&C Research LaboratoriesSolid tumours; Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms
상세
KT-333KT-333; I-003Phase 1 ClinicalKymera Therapeutics IncLymphoma, T-Cell, Peripheral; Solid tumours; Leukemia, Lymphoid; Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Leukemia, Large Granular Lymphocytic
상세
VVD-130850VVD-130850; BAY-3630914Phase 1 ClinicalSolid tumours
상세
DCR-STAT3DCR-STAT3Phase 1 ClinicalDicerna Pharmaceuticals IncSolid tumours; Neoplasms
상세
OPB-171775OPB-171775Phase 1 ClinicalOtsuka Pharmaceutical Co LtdMetabolic Dysfunction-Associated Steatotic Liver Disease
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
GolotimodSCV-07ApprovedVertaRussian FederationHepatitis C; Mucositisnull2009-01-01Head and Neck Neoplasms; Hepatitis C; Mucositis; Stomatitis
상세
Caffeic AcidCABEApprovedThe University Of Texas MD Anderson Cancer Center, Moleculin LlcHemorrhage; Leukopenia; Thrombocytopenia
상세
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호